Fulgent to present FID-007 cancer drug data at ASCO 2026 meeting May 21, 2026 05:03PM
Fulgent Genetics, Inc. (FLGT) call put ratio 2.6 calls to 1 put as share price up 5.8% May 21, 2026 01:57PM
Fulgent Genetics, Inc. (FLGT) Misses Q1 EPS by 25c ; Offers Guidance May 1, 2026 07:03AM
Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 22c Feb 27, 2026 07:05AM
Fulgent Genetics (FLGT) PT Raised to $36 at Raymond James Nov 14, 2025 04:21AM


Nov 7, 2025 07:09AM Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 36c ; Offers Guidance
Oct 20, 2025 06:01AM Fulgent shares preliminary FID-007 trial data at ESMO conference
Aug 5, 2025 02:57AM UBS Upgrades Fulgent Genetics (FLGT) to Buy
Aug 1, 2025 07:04AM Fulgent Genetics, Inc. (FLGT) Tops Q2 EPS by 25c, provides guidance
Jul 17, 2025 07:00AM Fulgent Genetics gets EU CE mark for genetic testing system
May 12, 2025 03:10PM Fulgent Genetics, Inc. (FLGT) October 30 calls active on 6600 contracts
May 2, 2025 07:02AM Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 12c ; Offers Guidance
Mar 7, 2025 05:22PM DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
Feb 28, 2025 07:02AM Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 43c ; Offers Guidance
Nov 8, 2024 07:05AM Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 46c ; Offers Guidance
Oct 31, 2024 08:03AM Fulgent Genetics (FLGT) Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans
Aug 2, 2024 07:02AM Fulgent Genetics, Inc. (FLGT) Tops Q2 EPS by 45c ; Offers Guidance